Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?
暂无分享,去创建一个
[1] D. J. Finney,et al. stematic Signalling of Adverse Reactions to Drugs , 1974, Methods of Information in Medicine.
[2] Gerald A. Faich,et al. Factors Affecting Physician Reporting of Adverse Drug Reactions , 1986 .
[3] C. E. Lumley,et al. The under-reporting of adverse drug reactions seen in general practice , 1986 .
[4] A. Pelech,et al. ASTEMIZOLE-INDUCED TORSADE DE POINTES , 1988, The Lancet.
[5] J. Vandenbroucke,et al. QT Interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population , 1991, Circulation.
[6] B McNutt,et al. Torsades de pointes occurring in association with terfenadine use. , 1991, JAMA.
[7] B. Stricker,et al. Serum sickness-like reactions to cefaclor. , 1992, Journal of clinical epidemiology.
[8] Y Chen,et al. Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.
[9] P. Schad,et al. Loratadine and ventricular tachycardia. , 1994, The American journal of cardiology.
[10] R. Meyboom,et al. Non-puerperal lactation associated with antidepressant drug use. , 2003, British journal of clinical pharmacology.
[11] L. Wilton,et al. Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study , 1998, BMJ.
[12] B. Knollmann,et al. Cardiac actions of erythromycin: influence of female sex. , 1998, JAMA.
[13] J A Kors,et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. , 1999, European heart journal.
[14] Arthur J. Moss,et al. The QT Interval and Torsade de Pointes , 1999, Drug safety.
[15] F. D. de Abajo,et al. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. , 1999, British journal of clinical pharmacology.
[16] R. Meyboom,et al. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. , 1999, British journal of clinical pharmacology.
[17] G. Pearce,et al. QT lengthening and life-threatening arrhythmias associated with fexofenadine. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.
[18] A. Hoes,et al. Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure. , 2000, Archives of internal medicine.